20/20 Biolabs, Inc. Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
20/20 BioLabs, Inc. (Nasdaq: AIDX) is a pioneering biotechnology company and early market leader in AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Operating from our CAP-accredited and CLIA-licensed laboratory in Gaithersburg, Maryland, we leverage advanced machine learning models and real-world data to provide affordable, accurate, and actionable health insights. Through our flagship OneTest™ brand, including OneTest for Cancer and the newly launched OneTest for Longevity. We empower individuals to track biological age, manage systemic inflammation, and lower disease risk through evidence-based dietary and lifestyle guidance. 20/20 BioLabs is committed to shifting healthcare from reactive treatment to proactive prevention By making precision diagnostics accessible to all through convenient, needle-free at-home collection and explainable AI.